Fig. 3
From: Hypertension in Cardio-Oncology Clinic: an update on etiology, assessment, and management
Pharmacological management of hypertension in cancer patients. Choosing the proper anti-hypertensive agent for cancer patients is essential in managing hypertension in these patients. ACE or ARB and CCB are the first-line treatment in hypertension treatment. In patients with resistant hypertention, beta-blockers, diuretics, and nitrates can be added to the therapeutic drugs. Beta-blockers are a good choice if cancer patients have high sympathetic tone, tumors with beta-receptor expression (such as angiosarcoma and multiple myeloma), and other cardiovascular comorbidities